首页> 外文期刊>Journal of Neuro-Oncology >Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas
【24h】

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas

机译:胶质瘤相关抗原在小儿脑干和非脑干神经胶质瘤中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

We investigated the protein expression of three glioma-associated antigens (GAAs) in pediatric brain stem glioma (BSG) and non-brain stem glioma (NBSG) cases with a view to their possible use in immunotherapy. Expression of EphA2, IL-13Rα2 and Survivin were studied by immunohistochemistry on paraffin-embedded tissues using a series of 15 BSG cases and 12 NBSG cases. Thirteen of 15 BSGs and all 12 NBSGs expressed at least one of GAAs; and 7 BSGs and 9 NBSGs expressed at least two of these GAAs at higher levels than non-neoplastic brain. There was no association between the tumor grade and levels of GAA expression. Although many cases demonstrated diffuse expression of GAAs throughout specimens, partial or patchy expression was noted in a small number of cases, suggesting a need for targeting multiple GAAs in immunotherapy. These results suggest that EphA2, IL-13Ralpha2 and Survivin are suitable targets for developing vaccine strategies for pediatric glioma.
机译:我们调查了三种神经胶质瘤相关抗原(GAA)在小儿脑干神经胶质瘤(BSG)和非脑干神经胶质瘤(NBSG)病例中的蛋白表达,以期在免疫治疗中可能使用。通过免疫组织化学方法,在15例BSG病例和12例NBSG病例中,通过免疫组织化学研究了EphA2,IL-13Rα2和Survivin的表达。 15个BSG中的13个和所有12个NBS中至少有一项表示了GAA; 7个BSG和9个NBSG中至少有2个表达的GAA高于非肿瘤性脑。肿瘤等级与GAA表达水平之间没有关联。尽管许多病例在整个标本中均表现出GAA的弥散表达,但在少数情况下仍会部分或部分表达,这表明在免疫治疗中有必要针对多种GAA。这些结果表明,EphA2,IL-13Ralpha2和Survivin是开发小儿神经胶质瘤疫苗策略的合适靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号